Latres E, Greenbaum CJ, Oyaski ML, Dayan CM, et al. Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes. Diabetes 2024 Feb 13:dbi230012. doi: 10.2337/dbi23-0012.
PMID: 38349844